INTRODUCTION
Studies in isolated aerobically perfused rat hearts (1, 2) have shown that high concentrations of free fatty acids (FFA)1 increased myocardial oxygen consumption (MVO2). Since augmentation of MVO2 has generally been attributed to increased mechanical performance through raised myocardial contractility, preload, developed tension, and heart rate (HR) (3), it is unclear whether the observed rise in MVO2 was due to increased myocardial performance or to a direct effect of FFA on myocardial metabolism. The present study was therefore undertaken to examine the possible MV 02-stimulating effect of high plasma-FFA in intact hearts under controlled hemodynamic conditions.
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1 Abbreviations used in this paper: CO, cardiac output; dP/dt, maximal rate of rise of left ventricular pressure; FFA, free fatty acids; HR, heart rate; LVP, left ventricular pressure; LVW, left ventricular work; MF, myocardial blood flow; MV02, myocardial oxygen consumption. (6) . H2-concentration was determined polarographically with a platinum electrode mounted on the tip of a cardiac catheter inserted under fluoroscopic guidance into the coronary sinus. The current obtained is linearly related to H2-concentration in the coronary sinus. The blood drained through the coronary sinus was regarded as representative of blood passing through the left ventricle of myocardium (7) . Blood flow in ml/min 100 g tissue was calculated from the half-times of the monoexponential desaturation curves, according to the formula where tj is the half-time in minutes. H2 tissue/blood partition coefficient and specific gravity were assumed to be 1.00. Hydrogen gas was given with respiratory air until stable concentrations were recorded in coronary sinus blood. Gas administration was then stopped, and 30-50 ml of 0.9% saline, saturated with hydrogen at 1 atmosphere, were injected into the left ventricle to maintain a constant hydrogen concentration in the myocardium for another 60 sec, ensuring immediate desaturation of arterial blood, at the end of the infusion. Hydrogen oxidation current was measured (10) . The magnitude of in vitro lipolysis during hypertriglyceridemia was studied in separate experiments. Plasma-FFA was unchanged 1 hr after blood sampling. When FFAextraction was delayed for 2 hr after blood sampling, plasma-FFA rose by 10-15%. This late effect was prevented when blood was sampled in tubes containing protamine sulphate. However, since extraction of FFA was performed within half-an-hour, pretreatment of tubes with protamine sulphate was not used in the routine procedure.
METHODS
Experimental procedure. After control registrations and blood sampling, plasma-FFA was elevated by continuous intravenous (i.v.) infusion of a fat emulsion, Intralipid "Vitrum," after heparinization (sodium heparin, 3 mg/kg, i.v.). 10% Intralipid was infused at a rate of 1.5-3.0 ml/ min for a period up to 45 min. Blood samples were obtained at 15, 30, and 45 min infusion. Arterial concentrations of FFA increased promptly and leveled off after 15 min. Tables I and II show mean values of hemodynamic and metabolic data obtained after 30 and 45 min infusion. 30 min after discontinuation of the Intralipid infusion, recovery registrations, and blood samples were obtained.
Calculations. Left ventricular work (LVW) (kg/min-kg) was calculated as 0.0136 X CO X LVSP (11), where CO is cardiac output (ml/min *kg) and LVSP left ventricular systolic pressure (mm Hg).
MV02 (ml/min-100 g) was calculated from the oxygen extraction of the myocard (02-extr.) and MF.
Myocardial uptake of FFA (ttEq/min 100 g) was calculated as the product of arterio-coronary sinus differences of FFA and myocardial plasma flow.
To evaluate differences, probability values were obtained utilizing Student's t test for paired data.
RESULTS
Mechanical performance before, during, and after Intralipid infusion, as measured by systolic and end-diastolic LVP, dP/dt, HR, CO, and LVW, remained unchanged (Table I) .
In all experiments, increased myocardial uptake of FFA was associated with augmented MVO2 (Fig. 1 ). Table II shows metabolic data before, during, and after Intralipid infusion. MVO2 increased on average from 8.6 to 10.7 ml/min 100 g (+ 26%, P <0.001) when FFA uptake rose on average from 5.7 to 22.0 i&Eq/min 100 g. The augmentation MVO2 was mainly due to elevated myocardial oxygen extraction. MF was unchanged or increased slightly. In the recovery period, MVO2 returned to normal.
DISCUSSION
The major finding in the present investigation was that elevated myocardial uptake of FFA was associated with increased MVO2.
Raised MVO2 was principally based on increased myocardial oxygen extraction while MF was virtually unchanged. Previous data have shown that the H2 desaturation technique is a sensitive and reliable method for measurements of MF (6) . Thus it is unlikely that a decrease in MF reciprocal to increased O-extraction would not have been registered, had it occurred.
The chief determinants of MVO2 are myocardial contractility, preload, developed tension, and HR (3). Mechanical factors, however, can be ruled out as responsible for the elevated MYO2, as systolic and enddiastolic LVP, dP/dt, CO, and HR remained unchanged during raised plasma-FFA. These results are in accordance with Henderson, Most, Parmley, Gorlin, and Sonnenblick (12) who found that FFA did not alter developed force in well-oxygenated rat papillary muscle.
Whether high arterial concentrations and myocardial uptake of FFA actually increase MVO in vivo has not been clearly established, and the experimental evidence is conflicting (1, 13).
The MVO2-stimulating effect of FFA has been demonstrated by Challoner and Steinberg (1, 2) in isolated perfused rat hearts; however, mechanical activity was not controlled in their experiments. Moreover, marked elevation of MVO2 generally required higher concentrations of FFA than those found in vivo.
Henderson and Sonnenblick (13) have recently shown that high concentrations of FFA actually decreased MVO2 in isolated rat hearts perfused at constant flow and paced at constant rate. On the other hand, myocardial performance was also markedly depressed, thus invalidating the interpretation of the relationship between FFA-uptake and MVO2.
A mechanism for the MVO2-stimulating action of FFA in vivo remains to be definitely established. Challoner and Steinberg (1, 2) suggested an uncoupling effect of high concentrations of FFA within myocardial cells on oxidative phosphorylation, as also demonstrated in isolated liver mitochondria (14) .
It is known that during increased myocardial uptake of FFA, a significant fraction of the FFA taken up is not immediately oxidized but stored in myocard as triglycerides. However, the amount of oxygen required for esterification of the additional amount of FFA taken up during high plasma-FFA is less than 10% of the observed increase in MVO2 (15) .
The induced levels of plasma-FFA in the present experiments are comparable with those seen during increased catecholamine activity. Augmented MYO2 during catecholamine stimulation-which has been difficult to attribute to augmented mechanical activity alone-may therefore be partly explained by the effect of FFA (2, 16) . The present results may also be rele- hemoglobin; the values for P are the highest probability that the observed differences are due to chance. NS, not significant (P > 0.05).
